Investing in AI tools for predictive analytics will be crucial in shaping the next phase of drug safety measures ...

Attention deficit hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder. Despite its significance, no large-scale epidemiological study assessing ADHD, and its associated ...

Current clinical practice lacks quantitative assessment methods for elbow joint movements. In response to existing research limitations, this study introduces the innovative elbow joint torque ...

ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere®, today announced that another top-tier pharmaceutical ...

ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere®, today announced ...

Pharmacovigilance evolves with technology, employing active surveillance to detect drug-related issues and ensure safety in ...

The recently introduced vaccination against the human papillomavirus (HPV) is an important step in fighting against cervical ...

This article examines post-market drug safety, highlighting surveillance mechanisms, regulatory responses, and case studies ...

The AI in pharmacovigilance market is expected to grow at a CAGR of 12–15% from 2023 to 2030, driven by the need to automate ...

ELIQUENT Life Sciences (ELIQUENT), a global regulatory, quality, and safety consulting firm, today announced the acquisition of Truliant Consulting (Truliant), a leading pharmacovigilance, risk ...

Additionally, this study is the first to use the FAERS database to reveal the potential association of 50 drugs with kidney stones, providing an important reference for pharmacovigilance and clinical ...